-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
August 01, 2014 - • Patient or surrogate decision maker declined or is unwilling to consent to therapies.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
January 01, 2019 - The National Institute of Mental Health works every day to
transform the understanding and treatment … Considerations for Implementation: To determine whether a patient is a candidate for
statin therapy, … Considerations for Implementation: To determine whether a patient is a candidate for
statin therapy, … D
Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women:
Primary Prevention … Considerations for Implementation: To determine whether a patient is a candidate for
statin therapy,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … The
RCTs evaluated patients who were not on oral
anticoagulation therapy (OAT) and had intracerebral … population targeted by the RCTs—
patients with intracerebral hemorrhage who were not
on anticoagulation therapy … There were insufficient studies to assess the
impact of rFVIIa on patients taking oral
anticoagulation therapy … with intracranial
hemorrhage secondary to TBI who were not on
anticoagulation therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
August 01, 2012 - The QI
process is designed to raise the standards of the
delivery of preventive, diagnostic, therapeutic … • In subanalysis at 5 years, QI–Therapy but not QI–Meds was
effective within the minority population … A medication-focused
intervention and a therapy-focused intervention decreased
a disparity gap between … • QI–Meds and QI–Therapy decreased “probable unmet need” disparity
gap between men and women from … 10% to 1% (QI–Meds) and 3%
(QI–Therapy) at 24 months.
-
www.ahrq.gov/sites/default/files/2024-12/selker-report.pdf
January 01, 2024 - In ED treatment, although the lifesaving impact of coronary reperfusion by thrombolytic therapy and … the ACI-TIPI-IS for patients with symptoms
of ACI and for patients w/ AMI who required reperfusion therapy … with thrombolytic therapy and coronary
angioplasty. … Effectiveness of
intravenous thrombolytic therapy in acute myocardial infarction. … project
phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy
-
psnet.ahrq.gov/node/50698/psn-pdf
November 27, 2019 - Successful completion
of this exercise can be therapeutic for patients and provides very useful information … means, lethal pain medications, and hot-spots for suicide by jumping.11 With respective to specific
therapeutic … interventions, modest benefits have been documented for cognitive behavioral therapy (CBT)
and dialectical … behavioral therapy (DBT), and some medications have been shown to reduce suicide rates
as compared … Evidence-based medication treatments for
“maintenance treatment” of alcohol use disorders are underutilized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - What are the benefits and harms of immediate
antibacterial, antiviral therapy, and/or hospitalization … antibiotic/antiviral therapy (vs. delaying until diagnostic
workup is complete) in patients at high … their antibiotic
treatment course.72
KQ 4. … In the absence of better data on harms
and the costs of diagnostics and therapeutics or improved
positive … The harms and costs of immediate therapy or management
in high-risk patients have been poorly reported
-
cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec
2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec
4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none
5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
June 20, 2013 - Topic 0552 Low Back Pain NSD FINAL SJ
Diagnosis and Treatment of Low … The nominator is also interested in the harms and benefits of the treatment
options. … interventions for secondary prevention or prevention of flares of low back pain, and
combination therapy … and related therapies, massage, and
various psychological therapies)
6. … What are the comparative benefits and harms of combinations of therapies (versus
single therapies or
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
January 01, 2008 - the comparative effectiveness of disease-modifying
antirheumatic drugs (DMARDs) and other medical treatments … for the treatment of
juvenile idiopathic arthritis. … and have no disease-modifying
properties))
Outcome(s): Potential harms and benefits of various treatments … subgroups of patients based on stage of disease, history of
prior therapy, demographics, concomitant … therapies, or comorbidities?
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional
therapies intended to modify the core symptoms of ASD
Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate
specific medical therapies from the review as treatments are typically
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional
therapies intended to modify the core symptoms of ASD
Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate
specific medical therapies from the review as treatments are typically
-
psnet.ahrq.gov/node/44231/psn-pdf
January 22, 2016 - Just-in-time training for high-risk low-volume therapies:
an approach to ensure patient safety. … Just-in-Time Training for High-Risk Low-Volume Therapies: An
Approach to Ensure Patient Safety. … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient … and competency shortcomings for bedside
nurses on an as-needed basis, given the demands of complex treatments … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient-safety